UNSPSC 51391709: Carbuterol

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0N12JR32MR. European Medicines Agency schedules Carbuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06621MIG. Carbuterol generally arises in the molecular formula C13H21N3O3.

UNSPSC 51391709 Carbuterol is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The two most recent records—a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI for direct-to-manufacturer pharmacy prescription programs—are pharmaceutical procurement activities with no connection to carbuterol, a bronchodilator medication. The mismatch suggests either a cataloging error in the state and local procurement system or that the code is not being used by state and local bodies for its intended purpose. No solicitations specifically targeting carbuterol supply, distribution, or related services appear in the recent activity.

Given the absence of relevant recent activity, this code does not support a pursue or watch decision at this time. Firms considering work in pharmaceutical supply to state and local health agencies should monitor whether this code's usage corrects or whether opportunities migrate to other UNSPSC family codes covering broader pharmaceutical procurement. The two posted records do signal ongoing state and local demand for specialized pharmaceutical products—naloxone for emergency response and direct-to-manufacturer prescription fulfillment—but neither relates to carbuterol specifically.